Skip to the page

Data / Form D filings / EnteroBiotix LTD

EnteroBiotix LTD: Form D filings

EnteroBiotix LTD, a biotechnology company in Glasgow, United Kingdom, filed 6 Form D notices with the SEC between 2022 and 2026. The latest, on April 9, 2026, reports $5.3 million sold of an offering with no set size to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
PHOENIX HOUSE STRATHCLYDE BUSINESS PARK, Glasgow, United Kingdom, ML4 3
Phone
00441698501370
Industry
Biotechnology
Entity type
Other
Incorporated in
United Kingdom
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1946072

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 9, 2026New noticeIndefinite$5,341,5936Mar 30, 2026sec.gov
Jul 25, 2025New noticeIndefinite$1,389,6762Jul 11, 2025sec.gov
Apr 9, 2024New noticeIndefinite$1,262,0001Mar 26, 2024sec.gov
Feb 2, 2024New noticeIndefinite$2,565,2253Jan 19, 2024sec.gov
Aug 14, 2023New noticeIndefinite$6,706,9413Aug 9, 2023sec.gov
Sep 14, 2022New notice$12,989,000$11,234,000$1,755,0005Aug 30, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Iain BairdDirector
Mark BamforthDirector
Elmar Josef SchneeDirector
James Roger McIlroyExecutive Officer, Director
Douglas Campbell ThomsonDirector
Strange MelissaExecutive Officer
Barnes JamesExecutive Officer

Every Form D from the week of Apr 6, 2026 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what EnteroBiotix LTD reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.